bioMerieux(BMXMF)
$101.99-0.34 (-0.33%)
BMXMF
bioMerieux financials statements
$101.99
At close:-0.34 (-0.33%)
bioMerieux (BMXMF) Income Statement
1 Followers
bioMerieux Income Statement
Last quarter (Q2 2026), bioMerieux's total revenue was €1.96B, an increase of 3.30% from the same quarter last year. In Q2, bioMerieux's net income was €226.10M. See bioMerieux’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 4.07B | € 3.98B | € 3.67B | € 3.59B | € 3.38B | |
| € 2.14B | € 2.22B | € 2.06B | € 1.96B | € 1.97B | |
| € 1.58B | € 1.63B | € 1.62B | € 1.40B | € 1.20B | |
| Depreciation and Amortization | € 438.40M | € 302.20M | € 259.40M | € 257.60M | € 220.40M |
| € 999.60M | € 897.50M | € 701.30M | € 811.90M | € 977.80M | |
| € 561.20M | € 588.80M | € 439.10M | € 559.80M | € 768.00M | |
| € -35.70M | € -9.50M | € -1.60M | € 20.70M | € -9.80M | |
| € 525.50M | € 579.30M | € 437.50M | € 550.20M | € 748.30M | |
| € 397.50M | € 432.20M | € 357.60M | € 452.40M | € 601.10M | |
| Per Share Metrics | |||||
| Basic EPS | € 3.37 | € 3.67 | € 3.03 | € 3.84 | € 5.08 |
| Diluted EPS | € 3.34 | € 3.64 | € 3.01 | € 3.82 | € 5.06 |
| Weighted Average Shares Outstanding | 117.95M | 117.77M | 118.05M | 117.95M | 118.27M |
| Weighted Average Shares Outstanding (Diluted) | 119.01M | 118.74M | 118.80M | 118.44M | 118.89M |
Currency in EUR
